Dabelea Dana, D'Agostino Ralph B, Mayer-Davis Elizabeth J, Pettitt David J, Imperatore Giuseppina, Dolan Larry M, Pihoker Catherine, Hillier Teresa A, Marcovina Santica M, Linder Barbara, Ruggiero Andrea M, Hamman Richard F
University of Colorado Health Sciences Center, Denver, Colorado, USA.
Diabetes Care. 2006 Feb;29(2):290-4. doi: 10.2337/diacare.29.02.06.dc05-1339.
The "accelerator hypothesis" predicts that fatness is associated with an earlier age at onset of type 1 diabetes. We tested the hypothesis using data from the SEARCH for Diabetes in Youth study.
Subjects were 449 youth aged <20 years at diagnosis who had positive results for diabetes antibodies measured 3-12 months after diagnosis (mean 7.6 months). The relationships between age at diagnosis and fatness were examined using BMI as measured at the SEARCH visit and reported birth weight, both expressed as SD scores (SDSs).
Univariately, BMI SDS was not related to age at diagnosis. In multiple linear regression, adjusted for potential confounders, a significant interaction was found between BMI SDS and fasting C-peptide (FCP) on onset age (P < 0.0001). This interaction remained unchanged after additionally controlling for number and titers of diabetes antibodies. An inverse association between BMI and age at diagnosis was present only among subjects with FCP levels below the median (<0.5 ng/ml) (regression coefficient -7.9, P = 0.003). A decrease of 1 SDS in birth weight (639 g) was also associated with an approximately 5-month earlier age at diagnosis (P = 0.008), independent of sex, race/ethnicity, current BMI, FCP, and number of diabetes antibodies.
Increasing BMI is associated with younger age at diagnosis of type 1 diabetes only among those U.S. youth with reduced beta-cell function. The intrauterine environment may also be an important determinant of age at onset of type 1 diabetes.
“加速假说”预测肥胖与1型糖尿病发病年龄较早有关。我们使用青少年糖尿病研究(SEARCH for Diabetes in Youth study)的数据对该假说进行了检验。
研究对象为449名诊断时年龄小于20岁的青少年,他们在诊断后3 - 12个月(平均7.6个月)测量的糖尿病抗体检测结果呈阳性。使用在SEARCH研究访视时测量的BMI以及报告的出生体重来检查诊断年龄与肥胖之间的关系,两者均表示为标准差分数(SDSs)。
单因素分析时,BMI SDS与诊断年龄无关。在多线性回归中,对潜在混杂因素进行校正后,发现BMI SDS与空腹C肽(FCP)在发病年龄上存在显著交互作用(P < 0.0001)。在进一步控制糖尿病抗体的数量和滴度后,这种交互作用保持不变。仅在FCP水平低于中位数(<0.5 ng/ml)的受试者中,BMI与诊断年龄之间存在负相关(回归系数 -7.9,P = 0.003)。出生体重降低1个SDS(639 g)也与诊断年龄提前约5个月相关(P = 0.008),且独立于性别、种族/族裔、当前BMI、FCP和糖尿病抗体数量。
仅在那些β细胞功能降低的美国青少年中,BMI升高与1型糖尿病诊断时年龄较小有关。子宫内环境也可能是1型糖尿病发病年龄的一个重要决定因素。